SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are experiencing significant volatility and selling pressure as traders debate whether the stock is being manipulated by institutional liquidation and option expiration activity, or if the decline is a reaction to founder Larry Ellison's pre-arranged plan to sell up to 50 million shares. While many investors remain bullish on the company's long-term AI infrastructure growth and recent earnings beat, others are concerned about high debt levels and aggressive capital expenditures.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

HPE is trending following strong quarterly earnings that featured record revenue and raised guidance, though the stock faced downward pressure as some investors expressed concerns over margin moderation and supply-chain constraints. While traders are debating whether the reaction is a temporary shakeout or a sign of deeper weakness, many highlight the company's robust backlog and ongoing AI infrastructure partnership with Oracle as long-term catalysts.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is trending following a decline attributed to a shift in sentiment after a community-shared survival model was revised, combined with rumors of institutional profit-taking and coordinated selling. Long-term shareholders maintain that the company's fundamentals and REGAL trial status remain unchanged, viewing the volatility as a market-driven shakeout rather than a reaction to new clinical data.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are under pressure following the company's launch of a new $1 billion at-the-market equity offering program. While some traders view the move as necessary capital-raising for long-term development, community sentiment is largely bearish due to concerns over continued shareholder dilution and ongoing insider stock sales.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

The conversation is primarily focused on the anticipation of positive updated full-year revenue guidance and potential forthcoming clinical catalysts, such as upcoming lung cancer trial data. Investors are maintaining a bullish outlook, highlighting the commercial progress of Amtagvi and expecting a favorable reception to management's upcoming conference presentations.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The Dow Jones Industrial Average snapped a four-day losing streak as energy prices stabilized and investors recalibrated expectations ahead of the upcoming Federal Reserve policy meeting. Despite initial volatility, market participants are closely monitoring inflation data and the probability of a rate hike as sentiment remains cautious.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Crude oil is trading with significant volatility as traders monitor the shifting status of U.S.-Iran negotiations and the potential impact on supply routes in the Strait of Hormuz. Sentiment remains divided, with some investors betting on a continued conflict-driven rally while others anticipate a sharp decline following recent reports of diplomatic progress and increased crude oil supply.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as traders debate its potential for a recovery, with some speculating on a "parabolic" breakout due to its utility in digital payments and upcoming regulatory developments, while others remain skeptical, citing long-term price declines and ongoing frustration with the project's performance.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as traders react to the resolution of its financing deal and a federal court ruling that supports the company's Santa Ynez pipeline restart. While some participants express caution regarding previous volatility and potential legal hurdles, others remain bullish on the production ramp-up and anticipated positive catalysts regarding federal regulatory support.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as traders focus on the company's progress toward regulatory milestones for its gene-editing platform, specifically the Biologics License Application (BLA) for its hereditary angioedema therapy. While sentiment is divided between optimism regarding potential FDA approval and commercialization and concerns over cash burn and short interest, institutional accumulation—notably by ARK—remains a central point of conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
